Diamond Biofund Inc. (TPE:6901)
19.90
-2.20 (-9.95%)
Apr 9, 2025, 1:35 PM CST
Diamond Biofund Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 126.23 | 2,103 | 333.84 | 18.14 | 28.52 | Upgrade
|
Short-Term Investments | 3,100 | - | - | 4.5 | 119.34 | Upgrade
|
Trading Asset Securities | 1,904 | 7,544 | 10,404 | 10,065 | 6,519 | Upgrade
|
Cash & Short-Term Investments | 5,130 | 9,647 | 10,738 | 10,087 | 6,667 | Upgrade
|
Cash Growth | -46.82% | -10.16% | 6.45% | 51.30% | 429.49% | Upgrade
|
Accounts Receivable | - | - | 1.87 | 1.69 | 1.86 | Upgrade
|
Other Receivables | 7.74 | 2.64 | 0.21 | - | 0.12 | Upgrade
|
Receivables | 7.74 | 2.64 | 2.08 | 1.69 | 1.98 | Upgrade
|
Other Current Assets | 1.78 | 6 | 0.59 | 0.08 | 0.08 | Upgrade
|
Total Current Assets | 5,140 | 9,656 | 10,741 | 10,089 | 6,669 | Upgrade
|
Property, Plant & Equipment | 134.99 | 124.81 | 5.7 | 43.87 | 55.63 | Upgrade
|
Long-Term Investments | 5,391 | 3,235 | 445.28 | 406.09 | 2,530 | Upgrade
|
Other Intangible Assets | 0.25 | 0.14 | 0.28 | - | - | Upgrade
|
Other Long-Term Assets | 9.04 | 25.77 | 2.59 | 83.68 | 2.69 | Upgrade
|
Total Assets | 10,675 | 13,042 | 11,194 | 10,623 | 9,257 | Upgrade
|
Accounts Payable | 18.91 | - | - | - | - | Upgrade
|
Current Portion of Leases | 23.9 | 15.23 | 3.67 | 8.73 | 7.7 | Upgrade
|
Current Income Taxes Payable | 120.68 | - | 83.26 | 105.58 | 1.69 | Upgrade
|
Other Current Liabilities | 44.13 | 50.73 | 57.13 | 83.24 | 104.51 | Upgrade
|
Total Current Liabilities | 207.62 | 65.96 | 144.06 | 197.55 | 113.9 | Upgrade
|
Long-Term Leases | 93.93 | 113.78 | - | 33.26 | 42.91 | Upgrade
|
Total Liabilities | 301.55 | 179.74 | 144.06 | 230.82 | 156.81 | Upgrade
|
Common Stock | 8,514 | 8,499 | 6,350 | 5,000 | 4,500 | Upgrade
|
Additional Paid-In Capital | 3,544 | 3,530 | 12.75 | 1.16 | - | Upgrade
|
Retained Earnings | -1,685 | 833.05 | 4,688 | 5,391 | 4,600 | Upgrade
|
Shareholders' Equity | 10,373 | 12,862 | 11,050 | 10,392 | 9,100 | Upgrade
|
Total Liabilities & Equity | 10,675 | 13,042 | 11,194 | 10,623 | 9,257 | Upgrade
|
Total Debt | 117.83 | 129.01 | 3.67 | 41.99 | 50.61 | Upgrade
|
Net Cash (Debt) | 5,012 | 9,518 | 10,734 | 10,045 | 6,616 | Upgrade
|
Net Cash Growth | -47.34% | -11.33% | 6.86% | 51.82% | 452.44% | Upgrade
|
Net Cash Per Share | 5.89 | 12.22 | 13.95 | 12.41 | 9.66 | Upgrade
|
Filing Date Shares Outstanding | 851.39 | 849.89 | 749.3 | 749.3 | 674.37 | Upgrade
|
Total Common Shares Outstanding | 851.39 | 849.89 | 749.3 | 749.3 | 674.37 | Upgrade
|
Working Capital | 4,932 | 9,590 | 10,597 | 9,892 | 6,555 | Upgrade
|
Book Value Per Share | 12.18 | 15.13 | 14.75 | 13.87 | 13.49 | Upgrade
|
Tangible Book Value | 10,373 | 12,862 | 11,050 | 10,392 | 9,100 | Upgrade
|
Tangible Book Value Per Share | 12.18 | 15.13 | 14.75 | 13.87 | 13.49 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.